Reach Us +1-218-451-2974


Les Shaw | OMICS International
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Les Shaw

 University of Pennsylvania, USA


Dr. Shaw is the Director of the Toxicology Laboratory and the Biomarker Research Laboratory at the Department of Pathology and Laboratory Medicine. Dr. Shaw’s longstanding clinical and research interests include development and qualification of drug biomarkers, for inclusion in clinical trials, assessment of mechanisms underlying their changes over time, and in selected instances, introduction into the clinical laboratory as lab tests. He currently is Co-Director of the Alzheimer's Disease Neuroimaging Initiative Biomarker Core and the Parkinson's Progression Markers Initiative in the Bioanalytics Core at the University of Pennsylvania. For the past twelve years he has led the qualification of biomarkers of Alzheimer's disease using immunoassays and high-sensitivity mass spectrometry and is now applying these technologies to Parkinson's disease biomarkers. Dr. Shaw has co-authored close to 250 publications.

Research Interest

Molecular Biology, Clinical Chemistry, Clinical Pharmacology and Therapeutics, Clinical Toxicology, Pathology and Medicine